03:05 AM EDT, 07/15/2024 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on July 11, 2024, sold 7,093 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,851,273. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 73,848 shares of the company, with 73,441 shares held directly and 407 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527624000075/xslF345X03/edgardoc.xml

Price: 263.00, Change: +2.49, Percent Change: +0.96